Cdc2: a monopotent or pluripotent CDK?

Cell Prolif. 2011 Jun;44(3):205-11. doi: 10.1111/j.1365-2184.2011.00753.x.

Abstract

Cell cycle progression is controlled by both extracellular and intracellular signalling molecules. It has been generally believed that cdc2/CDK1 only control G(2)-M transition in mammalian and many other higher eukaryotic cells. Accumulating evidence shows that cdc2 not only promotes G(2)-M transition but is also capable of regulating G(1) progress and G(1)-S transition via association with multiple interphase cyclins; cdc2 activity can be inhibited by p21 and p27, two traditional G(1) CDK inhibitors. In addition, cdc2-cyclin B controls pronuclear union in interphase fertilized eggs. These data suggest that cdc2 may be a pluripotent CDK. Although mechanisms responsible for the multiple functions of cdc2 remain to be further investigated, interactions of cdc2 with pRb and with several important transcription factors may provide a clue to the pluripotent role of cdc2.

Publication types

  • Review

MeSH terms

  • Animals
  • CDC2 Protein Kinase
  • CDC2-CDC28 Kinases / metabolism*
  • Cell Cycle
  • Cyclin B / metabolism*
  • Cyclin-Dependent Kinase 4 / metabolism
  • Cyclin-Dependent Kinase 6 / metabolism
  • Cyclin-Dependent Kinase Inhibitor p27 / metabolism
  • Cyclin-Dependent Kinases / metabolism*
  • Gene Expression Regulation*
  • Humans
  • Mice
  • Mice, Knockout
  • Models, Biological
  • Phosphorylation
  • p21-Activated Kinases / metabolism

Substances

  • Cyclin B
  • Cyclin-Dependent Kinase Inhibitor p27
  • p21-Activated Kinases
  • CDC2 Protein Kinase
  • CDC2-CDC28 Kinases
  • CDK1 protein, human
  • CDK4 protein, human
  • CDK6 protein, human
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinase 6
  • Cyclin-Dependent Kinases